Aptevo Therapeutics Q3 EPS $(0.50) Beats $(0.75) Estimate; Aptevo Closed A Public Offering For $5M And Raised An Additional $2M Through The Exercise Of Warrants In November 2023, The Funding Extends The Cash Runway For At Least The Next Twelve Months
Benzinga Newsdesk - Nov 14, 2023, 8:18AM